Market capitalization | $5.28m |
Enterprise Value | $33.30m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.41 |
P/S ratio (TTM) P/S ratio | 0.06 |
P/B ratio (TTM) P/B ratio | 0.24 |
Revenue growth (TTM) Revenue growth | 4.32% |
Revenue (TTM) Revenue | $81.43m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
1 Analyst has issued a forecast Grove Inc:
1 Analyst has issued a forecast Grove Inc:
Mar '24 |
+/-
%
|
||
Revenue | 81 81 |
4%
4%
|
|
Gross Profit | 22 22 |
20%
20%
|
|
EBITDA | -2.12 -2.12 |
56%
56%
|
EBIT (Operating Income) EBIT | -7.91 -7.91 |
26%
26%
|
Net Profit | -24 -24 |
463%
463%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Grove, Inc. engages in the business of developing, producing, marketing and selling raw materials, white label products and end consumer products containing the industrial hemp plant extract, Cannabidiol. The firm sells its products to consumer markets including the nutraceutical, beauty care, pet care and functional food sectors. The firm also produces primarily business-to-business Cannabidiol related trade show. Its segments include: Product Sales and Trade Show. The company was founded on September 5, 2018 and is headquartered in Henderson, NV.
Head office | United States |
CEO | Allan Marshall |
Website | www.upexi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.